GILD

BIB Biotechnology GILD RCUS Uncategorized

Arcus downgraded at Morgan Stanley on balanced risk-reward setup

Jan 8, 2026

AZN Biotechnology GILD MRK RPTX Uncategorized

Gilead to buy Repare Thera’s cancer candidate for up to $30M

Dec 24, 2025

ACLX Biotechnology GILD JNJ Uncategorized

Arcellx a new overweight at Wells Fargo on promise of multiple myeloma CAR-T asset

Dec 22, 2025

ASMB Biotechnology GILD Uncategorized

Gilead exercises license for Assembly Biosciences herpes programs

Dec 22, 2025

abbvie,-bristol-myers,-merck-among-latest-to-announce-us.-drug-pricing-deals:-reuters

ABBV AZN Biotechnology BMY GILD LLY MRK NVO NVS PFE RHHBY Uncategorized

AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters

Dec 19, 2025

Comments (11) LIgorko/iStock via Getty Images Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY),...

ABBV AMGN AZN Biotechnology BMY GILD GSK JNJ LLY MKGAF MRK NVO NVS PFE REGN SNY Uncategorized

More pharmas expected to sign drug pricing deals with Trump on Friday – report

Dec 17, 2025

Biotechnology CGEN GILD RCUS Uncategorized

Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug

Dec 12, 2025